ULBP5 (an NKG2D ligand) provides co-stimulatory signaling to the CLDN18.2-directed CAR-T cells but is not a primary killing target; cytolysis occurs only when the CAR engages CLDN18.2, with NKG2D–ULBP5 enhancing activation.